In vitro induction of natural killer T cells from embryonic stem cells prepared using somatic cell nuclear transfer

FASEB Journal

Volumn 22, Issue 7, 2008, Pages 2223-2231

  Wakao, Hiroshi ^a,c   Wakao, Rika ^b,c,d   Sakata, Sakura ^c   Iwabuchi, Kazuya ^b   Oda, Atsushi ^a   Fujita, Hiroyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c RIKEN   (Japan)

^d PHARMACEUTICALS AND MEDICAL DEVICES AGENCY   (Japan)

Author keywords

Adjuvant effect; In vitro differentiation; Transplantable lymphocytes; Tumor rejection

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CELL FUNCTION; CELL MATURATION; CELL NUCLEUS TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYONIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD3; CELL NUCLEUS; DNA-BINDING PROTEINS; EMBRYONIC STEM CELLS; GATA3 TRANSCRIPTION FACTOR; HUMANS; KILLER CELLS, NATURAL; NUCLEAR PROTEINS; NUCLEAR TRANSFER TECHNIQUES; RECEPTORS, INTERLEUKIN-7; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA;

EID: 46749084612     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-104687     Document Type: Article

References (36)

1. Keller, G. (2005) Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 19, 1129-1155
2. Doetschman, T. C., Eistetter, H., Katz, M., Schmidt, W., and Kemler, R. (1985) The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87, 27-45
3. Nakano, T., Kodama, H., and Honjo, T. (1994) Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 265, 1098-1101
4. Nakano, T. (1995) Lymphohematopoietic development from embryonic stem cells in vitro. Sem. Immunol. 7, 197-203
5. Cho, S. K., Webber, T. D., Carlyle, J. R., Nakano, T., Lewis, S. M., and Zuniga-Pflucker, J. C. (1999) Functional characterization of B lymphocytes generated in vitro from embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 96, 9797-9802
6. Schmitt, T. M., de Pooter, R. F., Gronski, M. A., Cho, S. K., Ohashi, P. S., and Zuniga-Pflucker, J. C. (2004) Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nat. Immunol. 5, 410-417
7. Kronenberg, M. (2005) Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23, 877-900
8. Taniguchi, M., Harada, M., Kojo, S., Nakayama, T., and Wakao, H. (2003) The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21, 483-513
9. Bendelac, A., Rivera, M. N., Park, S. H., and Roark, J. H. (1997) Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15, 535-562
10. Kronenberg, M., and Rudensky, A. (2005) Regulation of immunity by self-reactive T cells. Nature 435, 598-604
11. Godfrey, D. I., and Kronenberg, M. (2004) Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114, 1379-1388
12. Smyth, M. J., Crowe, N. Y., Hayakawa, Y., Takeda, K., Yagita, H., and Godfrey, D. I. (2002) NKT cells - conductors of tumor immunity? Curr. Opin. Immunol. 14, 165-171
13. Stewart, T. J., Smyth, M. J., Fernando, G. J., Frazer, I. H., and Leggatt, G. R. (2003) Inhibition of early tumor growth requires Jalpha18-positive (natural killer T) cells. Cancer Res. 63, 3058-3060
14. Crowe, N. Y., Smyth, M. J., and Godfrey, D. I. (2002) A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J. Exp. Med. 196, 119-127
15. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J., and Baxter, A. G. (2000) NKT cells: facts, functions and fallacies. Immunol. Today 21, 573-583
16. Fujii, S., Shimizu, K., Smith, C., Bonifaz, L., and Steinman, R. M. (2003) Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198, 267-279
17. Inoue, K., Wakao, H., Ogonuki, N., Miki, H., Seino, K., Nambu-Wakao, R., Noda, S., Miyoshi, H., Koseki, H., Taniguchi, M., and Ogura, A. (2005) Generation of cloned mice by direct nuclear transfer from natural killer T cells. Curr. Biol. 15, 1114-1118
18. Wakao, H., Kawamoto, H., Sakata, S., Inoue, K., Ogura, A., Wakao, R., Oda, A., and Fujita, H. (2007) A novel mouse model for invariant NKT cell study. J. Immunol. 179, 3888-3895
19. Gapin, L., Matsuda, J. L., Surh, C. D., and Kronenberg, M. (2001) NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2, 971-978
20. Egawa, T., Eberl, G., Taniuchi, I., Benlagha, K., Geissmann, F., Hennighausen, L., Bendelac, A., and Littman, D. R. (2005) Genetic evidence supporting selection of the Valpha 14iNKT cell lineage from double-positive thymocyte precursors. Immunity 22, 705-716
21. Bendelac, A., Hunziker, R. D., and Lantz, O. (1996) Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J. Exp. Med. 184, 1285-1293
22. Benlagha, K., Kyin, T., Beavis, A., Teyton, L., and Bendelac, A. (2002) A thymic precursor to the NK T cell lineage. Science 296, 553-555
23. Benlagha, K., Wei, D. G., Veiga, J., Teyton, L., and Bendelac, A. (2005) Characterization of the early stages of thymic NKT cell development. J. Exp. Med. 202, 485-492
24. Rothenberg, E. V., and Dionne, C. J. (2002) Lineage plasticity and commitment in T-cell development. Immunol. Rev. 187, 96-115
25. Baldwin, T. A., Hogquist, K. A., and Jameson, S. C. (2004) The fourth way? Harnessing aggressive tendencies in the thymus. J. Immunol. 173, 6515-6520
26. Bradbury, A., Calabi, F., and Milstein, C. (1990) Expression of CD1 in the mouse thymus. Eur. J. Immunol. 20, 1831-1836
27. Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C. R., Koezuka, Y., and Kronenberg, M. (2000) Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192, 741-754
28. Gonzalez-Aseguinolaza, G., Van Kaer, L., Bergmann, C. C., Wilson, J. M., Schmieg, J., Kronenberg, M., Nakayama, T., Taniguchi, M., Koezuka, Y., and Tsuji, M. (2002) Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 195, 617-624
29. Liu, K., Iyoda, T., Saternus, M., Kimura, Y., Inaba, K., and Steinman, R. M. (2002) Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196, 1091-1097
30. + cells. J. Immunol. 164, 2412-2418
31. + T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182, 2091-2096
32. Shimizu, K., Kurosawa, Y., Taniguchi, M., Steinman, R. M., and Fujii, S. (2007) Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells. J. Exp. Med. 204, 2641-2653
33. Shimizu, K., Goto, A., Fukui, M., Taniguchi, M., and Fujii, S. (2007) Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice. J. Immunol. 178, 2853-2861
34. Parekh, V. V., Wilson, M. T., Olivares-Villagomez, D., Singh, A. K., Wu, L., Wang, C. R., Joyce, S., and Van Kaer, L. (2005) Glycolipid antigen induces long-term natural killer T cell anergy in mice. J. Clin. Invest. 115, 2572-2583
35. Ambrosino, E., Terabe, M., Halder, R. C., Peng, J., Takaku, S., Miyake, S., Yamamura, T., Kumar, V., and Berzofsky, J. A. (2007) Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis. J. Immunol. 179, 5126-5136
36. Terabe, M., and Berzofsky, J. A. (2007) NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis. Trends Immunol. 28, 491-496